Lund Papers in Economic History,
Lund University, Department of Economic History

Abstract: This paper sets up a quasi-experiment to estimate both total and heterogeneous impacts of medical innovations on the individual’s economic outcomes for a comprehensive set of around 90 health conditions. The rich administrative panel data for Sweden covering more than 1 million individuals combined with disease-specific data on new molecular entities and patents granted in healthcare have allowed me to emulate such an experiment. I find that an increase in medical innovations by one standard deviation raises disposable family income by 14.8% [95% CI: 14.4%; 15.1%]. Regarding the sources of income response, medical innovations strongly influence not only own disposable and labour income and sickness and unemployment payments but also a spouse’s income. The effects of medical innovations are especially strong for cancer and circulatory diseases, are moderate for mental and nervous, infectious and respiratory diseases, and are absent or appear as losses for other health shocks. Results also suggest decreasing returns – yet far from reaching zeros – rather than constant returns to scale.

Keywords: medical innovation; health shock; disposable income; difference-in-differences approach; Sweden

JEL-codes: I12; I14; I24; J22; J24; O31

71 pages, August 26, 2021

Full text files

a8e5c70c-6b9d-4dbf-bc41-4be1ba4c0b6b  Full text

Download statistics

• Lund University, Department of Economic History
• Home page for this series

Questions (including download problems) about the papers in this series should be directed to Tobias Karlsson ()
Report other problems with accessing this service to Sune Karlsson ().

This page generated on 2024-02-05 17:12:36.